Tenax Therapeutics Statistics Share Statistics Tenax Therapeutics has 4.56M
shares outstanding. The number of shares has increased by 33.84%
in one year.
Shares Outstanding 4.56M Shares Change (YoY) 33.84% Shares Change (QoQ) 9.98% Owned by Institutions (%) 5.48% Shares Floating 4.51M Failed to Deliver (FTD) Shares 284 FTD / Avg. Volume 0.54%
Short Selling Information The latest short interest is 275.37K, so 6.04% of the outstanding
shares have been sold short.
Short Interest 275.37K Short % of Shares Out 6.04% Short % of Float 6.22% Short Ratio (days to cover) 5.5
Valuation Ratios The PE ratio is -5.37 and the forward
PE ratio is -3.06.
Tenax Therapeutics's PEG ratio is
0.06.
PE Ratio -5.37 Forward PE -3.06 PS Ratio 0 Forward PS 8.3 PB Ratio 1.03 P/FCF Ratio -6.38 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tenax Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 20.6,
with a Debt / Equity ratio of 0.
Current Ratio 20.6 Quick Ratio 20.6 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -847.57
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-4.4M Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 130.79% in the
last 52 weeks. The beta is 1.58, so Tenax Therapeutics's
price volatility has been higher than the market average.
Beta 1.58 52-Week Price Change 130.79% 50-Day Moving Average 6.25 200-Day Moving Average 6.1 Relative Strength Index (RSI) 89.35 Average Volume (20 Days) 53,012
Income Statement
Revenue n/a Gross Profit n/a Operating Income -19.49M Net Income -17.6M EBITDA -17.58M EBIT -17.63M Earnings Per Share (EPS) -1.15
Full Income Statement Balance Sheet The company has 94.85M in cash and 0 in
debt, giving a net cash position of 94.85M.
Cash & Cash Equivalents 94.85M Total Debt n/a Net Cash n/a Retained Earnings -314.86M Total Assets 105.86M Working Capital 103.33M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.81M
and capital expenditures 0, giving a free cash flow of -14.81M.
Operating Cash Flow -14.81M Capital Expenditures n/a Free Cash Flow -14.81M FCF Per Share -0.97
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields TENX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TENX is $16,
which is 111.4% higher than the current price. The consensus rating is "Buy".
Price Target $16 Price Target Difference 111.4% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 3, 2024. It was a
backward
split with a ratio of 1:80.
Last Split Date Jan 3, 2024 Split Type backward Split Ratio 1:80
Scores Altman Z-Score 3.57 Piotroski F-Score 2
